Verrica Pharmaceuticals Inc (VRCA) Down 6.91% in Premarket Trading

Verrica Pharmaceuticals Inc (VRCA) is down Thursday morning, with the stock decreasing -6.91% in pre-market trading to 2.02. VRCA's short-term technical score of 7 indicates that the stock has traded less bullishly over the last month than 93% of stocks on the market. In the Biotechnology industry, which ranks 118 out of 146 industries, the stock ranks higher than 10% of stocks. Verrica Pharmaceuticals Inc has risen 8.50% over the past month, closing at $1.95 on June 2. During this period of time, the stock fell as low as $1.95 and as high as $2.52. VRCA has an average analyst recommendation of Strong Buy. The company has an average price target of $13.83.

VRCA has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on VRCA!

See Full VRCA Report

Verrica Pharmaceuticals Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 88 by this metric, VRCA ranks better than 88% of stocks.

Important Dates for Investors in VRCA:

-Verrica Pharmaceuticals Inc is set to release earnings on 8/9/2022. Over the last 12 months, the company has reported EPS of $-1.56. -We do not have a set dividend date for Verrica Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Verrica Pharmaceuticals Inc (VRCA)